Research Article
Relationship of Serum IL-12 to Inflammation, Hematoma Volume, and Prognosis in Patients With Intracerebral Hemorrhage
Table 1
Demographics and serum IL-12 levels in controls and patients.
| | Variables | Control (n = 100) | Patients (n = 209) | value |
| | Gender (male/female) | 54/46 | 121/88 | 0.518 | | Age (years) | 65.9 ± 21.3 | 66.7 ± 18.7 | 0.812 | | Admission time (hours) | — | 5.8 (7.0) | — | | Blood collection time (hours) | — | 6.9 (10.2) | — | | Initial SBP (mmHg) | — | 160.3 ± 27.3 | — | | Initial DBP (mmHg) | — | 91.5 ± 18.4 | — | | Hypertension (n (%)) | — | 135 (64.6) | — | | Current smoking (n (%)) | — | 67 (32.1) | — | | Atrial fibrillation (n (%)) | — | 46 (22.0) | — | | Lobar hemorrhage (n (%)) | — | 45 (21.5) | — | | Infratentorial hemorrhage (n (%)) | — | 37 (17.7) | — | | Intraventricular hemorrhage (n (%)) | — | 49 (23.4) | — | | Admission NIHSS | — | 10 (10) | — | | Hematoma volume (mL) | — | 16.9 (14.8) | — | | WBC (×109/L) | 8.9 ± 2.3 | 9.6 ± 3.1 | 0.039 | | Serum glucose (mmol/L) | 7.1 ± 1.2 | 7.4 ± 1.3 | 0.043 | | Serum CRP (mg/L) | 2.0 (0.8) | 22.3 (10.0) | 0.041 | | Serum TNF-α (pg/mL) | 28.6 (26.3) | 63.2 (23.2) | <0.001 | | Serum IL-12 (pg/mL) | 20.4 (19.1) | 71.5 (28.5) | <0.001 |
|
|
